-The Economic Times NEW DELHI: As patent wars heat up in the pharma space, mobile phone messages and Right to Information filings have emerged as potent weapons in the hands of multinationals keen to delay competition from low-cost generic versions of their patented products in India. Innovator drugmakers, who used to strike with patent suits after generic drugmakers released their versions in the market, have started gleaning information from text messages sent...

-The Economic Times NEW DELHI: Narendra Modi's Gujarat government, lauded by India Inc for being business friendly, has stumped industry as it seeks to back out of the high tariffs contracted for nearly 1,000 MW of solar plants of the Tatas, GMR, Adani, Bollywood star Ajay Devgn, Lanco and others. Industry leaders said the move was shocking as it raised issues about the consistency of the state's policy, but the business-savvy Gujarat...

-The Economic Times CHENNAI: India's patent appeals board has denied Monsanto a patent for a genetically-engineered method of increasing climate resilience in plants. The decision is significant not only for Monsanto's loss of possible exclusivity in an increasingly important segment but also for the interpretation of India's home-grown clauses in patent law - these are unpopular with global companies - for the first time in the case of plants. The Intellectual Property...

-The Economic Times NEW DELHI: India's much-delayed Twelfth Five-Year Plan is yet to be officially printed, but the Planning Commission has already begun asking states and ministries to start gearing up for the mid-term appraisals for this Plan period, leaving most of them bewildered. This Five-Year Plan started in April 2012, but the strategy document for the Plan was finalised and approved by National Development Council in late December that year -...

-The Telegraph The proliferation and sales of anti-diabetes combination pills that contain two drugs to control blood sugar has stirred concerns in medical circles that a large proportion of diabetes patients in India are not receiving ideal treatment. A study by Indian and British researchers has shown that such two-drug combo pills accounted for more than half of the sales of all oral anti-diabetes medications in India last year, although doctors say...